Development of an improved animal model of experimental autoimmune myositis

Area of Science:

• Immunology
• Neurology
• Pathology

Background:

• Experimental autoimmune myositis (EAM) animal models are crucial for studying autoimmune muscle diseases.
• Existing EAM models exhibit significant variability in disease severity and reproducibility.
• There is a need for a more robust and reliable EAM model.

Purpose of the Study:

• To develop a more severe and reproducible mouse model of EAM.
• To investigate the effect of increased dosage and frequency of myosin vaccination combined with pertussis toxin (PT).

Main Methods:

• BALB/c mice were subjected to two vaccination protocols: low-dose myosin (1 mg) four times with PT, or high-dose myosin (1.5 mg) twice with PT.
• Muscle strength, EMG duration, serum creatine kinase levels, and inflammatory infiltration were assessed.
• T cell infiltration (CD4+, CD8+) and MHC-I expression in muscle tissue were analyzed.

Main Results:

• The high-dose myosin and PT vaccination (M-EAM) induced significant EAM, characterized by reduced muscle strength, decreased EMG duration, and elevated creatine kinase.
• M-EAM mice showed prevented weight gain compared to controls and experienced significantly less muscle strength reduction.
• All M-EAM mice survived, unlike the low-dose group where 3 out of 16 died; M-EAM also promoted T cell infiltration and MHC-I upregulation.

Conclusions:

• The modified vaccination protocol using higher dose myosin and PT provides a more severe and reproducible EAM model.
• This new model is efficient, time-saving, and easily replicable for autoimmune myositis research.
• The findings highlight the model's utility for studying the pathogenesis and potential treatments of autoimmune myositis.